Balance Sheet
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average) (2016 - 2023)

Ascendis Pharma A (ASND) has disclosed Shares Outstanding (Diluted Average) for 8 consecutive years, with $7.0 million as the latest value for Q4 2023.

  • Quarterly Shares Outstanding (Diluted Average) changed 0.23% to $7.0 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Dec 2023, changed 0.23% year-over-year, with the annual reading at $7.0 million for FY2023, 0.23% changed from the prior year.
  • Shares Outstanding (Diluted Average) hit $7.0 million in Q4 2023 for Ascendis Pharma A, roughly flat from $7.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $8.1 million in Q4 2021 to a low of $6.4 million in Q4 2019.
  • Historically, Shares Outstanding (Diluted Average) has averaged $7.2 million across 5 years, with a median of $7.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 13.78% in 2020 and later fell 13.6% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $6.4 million in 2019, then grew by 13.78% to $7.3 million in 2020, then rose by 10.57% to $8.1 million in 2021, then fell by 13.6% to $7.0 million in 2022, then rose by 0.23% to $7.0 million in 2023.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ASND at $7.0 million in Q4 2023, $7.0 million in Q4 2022, and $8.1 million in Q4 2021.